BRPI0618956A8 - special food product comprising 5-d-fructose dehydrogenase, pharmaceutical composition containing 5-d-fructose dehydrogenase in combination with one or more enzymes, use of 5-d-fructose dehydrogenase, process of preparing a food product and composition ingestible by a mammal - Google Patents
special food product comprising 5-d-fructose dehydrogenase, pharmaceutical composition containing 5-d-fructose dehydrogenase in combination with one or more enzymes, use of 5-d-fructose dehydrogenase, process of preparing a food product and composition ingestible by a mammalInfo
- Publication number
- BRPI0618956A8 BRPI0618956A8 BRPI0618956A BRPI0618956A BRPI0618956A8 BR PI0618956 A8 BRPI0618956 A8 BR PI0618956A8 BR PI0618956 A BRPI0618956 A BR PI0618956A BR PI0618956 A BRPI0618956 A BR PI0618956A BR PI0618956 A8 BRPI0618956 A8 BR PI0618956A8
- Authority
- BR
- Brazil
- Prior art keywords
- fructose dehydrogenase
- food product
- fructose
- dehydrogenase
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/99—Oxidoreductases acting on the CH-OH group of donors (1.1) with other acceptors (1.1.99)
- C12Y101/99011—Fructose 5-dehydrogenase (1.1.99.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01005—Xylose isomerase (5.3.1.5)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
produto alimentício especial compreendendo 5-d-frutose desidrogenase, composição farmacêu-tica contendo 5-d-frutose desidrogenase em combinação com uma ou mais enzimas, uso de 5-d-frutose desidrogena-se, processo de preparação de um produto alimentício e composição ingerivel por um mamíferoa presente invenção refere-se a um agente para redução do teor de caloria utilizável do alimento, que contém um composto que efetua a desidrogenação de frutose em 5-ceto-d-frutose. além disso, é descrito um agente de combinação que também contém um composto que converte glicose em frutose. estes agentes podem ser usados, em particular, na terapia de adiposidade (obesidade).special food product comprising 5-d-fructose dehydrogenase, pharmaceutical composition containing 5-d-fructose dehydrogenase in combination with one or more enzymes, use of 5-d-fructose dehydrogenase, process of preparing a food product and composition A mammal-ingestible present invention relates to a usable calorie-lowering agent of the food, which contains a compound which effects fructose dehydrogenation on 5-keto-d-fructose. In addition, a combining agent is also described which also contains a compound that converts glucose to fructose. These agents may be used, in particular, in adiposity (obesity) therapy.
Applications Claiming Priority (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005056170 | 2005-11-23 | ||
DE102005056170.5 | 2005-11-23 | ||
DE102005060767 | 2005-12-16 | ||
DE102005060767.5 | 2005-12-16 | ||
DE102005061330.6 | 2005-12-20 | ||
DE102005061330 | 2005-12-20 | ||
DE102005063194 | 2005-12-30 | ||
DE102005063194.0 | 2005-12-30 | ||
DE102006001016 | 2006-01-05 | ||
DE102006001016.7 | 2006-01-05 | ||
US75741306P | 2006-01-10 | 2006-01-10 | |
US60/757,413 | 2006-01-10 | ||
DE102006013623A DE102006013623A1 (en) | 2005-11-23 | 2006-03-22 | New 5-D-fructose-dehydrogenase useful e.g. as a medicament, food, dietetic food, food additives or a balanced diet and for the therapy of adiposity |
DE102006013623.3 | 2006-03-22 | ||
DE102006014420.1 | 2006-03-27 | ||
DE102006014420A DE102006014420A1 (en) | 2006-03-27 | 2006-03-27 | New 5-D-fructose dehydrogenase in combination with an enzyme, e.g. glucose isomerase, useful for preventing or treating adiposity |
US83117306P | 2006-07-17 | 2006-07-17 | |
US60/831,173 | 2006-07-17 | ||
PCT/EP2006/011231 WO2007059955A2 (en) | 2005-11-23 | 2006-11-23 | Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0618956A2 BRPI0618956A2 (en) | 2011-09-13 |
BRPI0618956A8 true BRPI0618956A8 (en) | 2019-04-30 |
BRPI0618956B1 BRPI0618956B1 (en) | 2020-03-17 |
BRPI0618956B8 BRPI0618956B8 (en) | 2021-05-25 |
Family
ID=44546177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0618956A BRPI0618956B8 (en) | 2005-11-23 | 2006-11-23 | special food product comprising 5-d-fructose dehydrogenase, pharmaceutical composition containing 5-d-fructose dehydrogenase in combination with one or more enzymes, use of 5-d-fructose dehydrogenase, process of preparing a food product and composition ingestible by a mammal |
Country Status (3)
Country | Link |
---|---|
BR (1) | BRPI0618956B8 (en) |
ES (1) | ES2707785T3 (en) |
NZ (1) | NZ569118A (en) |
-
2006
- 2006-11-23 BR BRPI0618956A patent/BRPI0618956B8/en not_active IP Right Cessation
- 2006-11-23 NZ NZ569118A patent/NZ569118A/en not_active IP Right Cessation
- 2006-11-23 ES ES06818755T patent/ES2707785T3/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2707785T3 (en) | 2019-04-05 |
BRPI0618956B1 (en) | 2020-03-17 |
BRPI0618956A2 (en) | 2011-09-13 |
BRPI0618956B8 (en) | 2021-05-25 |
NZ569118A (en) | 2011-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY33700A (en) | ? PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS ?. | |
BRPI0611717A2 (en) | compound, pharmaceutical composition and use of the compound | |
BRPI0713182A8 (en) | uses of adapalene or one of its pharmaceutically acceptable salts, kit and product | |
UY29410A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON METHODAMIDES OF ACID 4- (4 - / - 3 (-4-CHLORO-3-TRIFLUOROMETIFENIL) UREIDO) FENOXI) PIRIDIN-2-CARBOXYLIC, PREPARATION PROCEDURE AND APPLICATIONS. | |
UY28931A1 (en) | USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
BRPI0414876A (en) | pharmaceutical compounds and compositions for the prevention of overdose or abuse and their uses | |
ECSP077299A (en) | NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORO-3-TRIFLUOROMETIL-FENIL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | |
BRPI0617294B8 (en) | pharmaceutical composition in hydroalcoholic gel and use of testosterone | |
BRPI0418148A (en) | compound, prodrug of a compound, gpr40 receptor function modulator, pharmaceutical agent, use of a compound and methods of modifying a gpr40 receptor function in a mammal, prophylaxis or treating diabetes in a mammal and producing a compound | |
BR0315867A (en) | Compositions and methods for oxybutynin transdermal therapy | |
BR112015022514A2 (en) | compositions comprising selenium and their use for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction | |
BR0316310A (en) | Pharmaceutical compositions having a modified vehicle | |
EA201001285A1 (en) | APPLICATION OF 25-OH D3 FOR IMPACT ON HUMAN MUSCLE PHYSIOLOGY | |
BRPI0718176B8 (en) | extended and controlled release semi-solid formulation, process for the preparation of semi-solid pharmaceutical composition | |
BR0107157A (en) | Diagnosis and treatment of cardiovascular conditions | |
MX2008007462A (en) | Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases. | |
BR112014027884A2 (en) | pharmaceutical combinations for treatment of metabolic disorders | |
BR112012028657A2 (en) | cocoa powder compositions | |
BRPI0602397A (en) | use and formulations of nitrosating agents for the treatment of liver fat disease | |
BR0315346A (en) | Method for the treatment or prevention of vasomotor symptoms in a patient, pharmaceutical formulation and use of norepinephrine reuptake inhibitor in combination with 5-h2a antagonist | |
BRPI0605654A (en) | nickel-based catalyst composition | |
BR112012016025A2 (en) | benzamide compound | |
BRPI0618956A8 (en) | special food product comprising 5-d-fructose dehydrogenase, pharmaceutical composition containing 5-d-fructose dehydrogenase in combination with one or more enzymes, use of 5-d-fructose dehydrogenase, process of preparing a food product and composition ingestible by a mammal | |
BR112014027213A2 (en) | New Alfentanil Composition for Acute Pain Treatment | |
BR112014007829A2 (en) | composition for use in promoting magnesium absorption and / or magnesium retention |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DA 4A ANUIDADE. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A23L 33/10 (2016.01), A23L 33/20 (2016.01), A23L 3 |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: PRONATURA GESELLSCHAFT FUER GESUNDE ERNAEHRUNG MBH |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/03/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 4A ANUIDADE. |
|
B21H | Extinguishment of a patent or of a certificate of addition of invention: decision cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2604 DE 01/12/2020 POR TER SIDO INDEVIDA. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/11/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |